| IGF1R |
IGF1R: Insulin-like growth factor 1 receptor precursor |
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
31.230 |
Evidence |
|
| THBS1 |
THBS1, TSP, TSP1: Thrombospondin-1 precursor |
EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
31.230 |
Evidence |
|
| CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
31.230 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
31.230 |
Evidence |
|
| JUN |
JUN: Transcription factor AP-1 |
ETS1 |
ETS1, EWSR2: Protein C-ets-1 |
31.230 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
CDK5 |
CDK5: Cell division protein kinase 5 |
31.230 |
Evidence |
|
| FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
31.230 |
Evidence |
|
| STAM2 |
STAM2: Signal transducing adapter molecule 2 |
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
31.230 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
CDK5 |
CDK5: Cell division protein kinase 5 |
31.230 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
HPCAL1 |
HPCAL1, BDR1: Hippocalcin-like protein 1 |
31.230 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
31.230 |
Evidence |
|
| WASPIP |
IPI00552369 |
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
31.230 |
Evidence |
|
| PLD2 |
PLD2: Phospholipase D2 |
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
31.230 |
Evidence |
|
| APS |
SH2B2, APS: SH2B adapter protein 2 |
CRKL |
CRKL: Crk-like protein |
31.230 |
Evidence |
|
| CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
31.230 |
Evidence |
|
| STX12 |
STX12: Syntaxin-12 |
VAMP8 |
VAMP8: Vesicle-associated membrane protein 8 |
31.180 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
SHB |
SHB: SH2 domain-containing adapter protein B |
31.180 |
Evidence |
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
VAV3 |
VAV3: Protein vav-3 |
31.180 |
Evidence |
|
| NEK8 |
NEK8, JCK, NEK12A: Serine/threonine-protein kinase Nek8 |
NEK7 |
NEK7: Serine/threonine-protein kinase Nek7 |
31.110 |
Evidence |
|
| TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
31.110 |
Evidence |
|
| ARHGEF7 |
IPI00449908 |
GIT2 |
IPI00238218 |
31.110 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
MKNK1 |
MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 |
31.110 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
RPS6KA2 |
RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 |
31.110 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
PLK1 |
PLK1, PLK: Serine/threonine-protein kinase PLK1 |
31.110 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
31.110 |
Evidence |
|